Medelife geht ab
denke mal morgen gibt es zahlen und hoffe das die ein wenig besser werden wie zuletzt
Date : 05/17/2010 @ 5:19PM
Source : Edgar (US Regulatory)
Stock : (MDFI)
Quote : 0.0058 0.0 (0.00%) @ 8:38AM
- Notification that Quarterly Report will be submitted late (NT 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One): [] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q
[ ] Form N-SAR [ ] Form N-CSR
For Period Ended: March 31, 2010
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
§
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
MEDEFILE INTERNATIONAL, INC.
Full name of Registrant
N/A
Former Name if Applicable
301 Yamato Road, Suite 315
Address of Principal Executive Office (Street and Number)
Boca Raton, FL 33431
City, State and Zip Code
1
PART II - RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)
(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
[X]
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report portion thereof could not be filed within the prescribed time period.
(Attach extra sheets if needed.)
The compilation, dissemination and review of the information required to be presented in the Form 10-Q for the relevant period has imposed time constraints that have rendered timely filing of the Form 10-Q impracticable without undue hardship and expense to the registrant. The registrant undertakes the responsibility to file such report no later than five days after its original prescribed due date.
PART IV - OTHER INFORMATION
(1)
§
Name and telephone number of person to contact in regard to this notification
Milton Hauser (561) 912-3393
(Name) (Area Code) (Telephone Number)
(2)
§
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). Yes [X] No [ ]
(3)
§
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes [ ] No [ X]
If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
2
MEDEFILE INTERNATIONAL, INC.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Date: May 17, 2010
By:§
§/s/ Milton Hauser
Milton Hauser
President and Chief Executive Officer
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.
Optionen
| Boardmail an "weckste" |
Wertpapier: Medefile International |
MedeFile Strengthens Balance Sheet by $900,000
BOCA RATON, Fla., May 27 /PRNewswire-FirstCall/ -- MedeFile International, Inc. (BULLETIN BOARD: MDFI) , a company specializing in portable electronic medical records management solutions, announced today that the Company has completed the next phase of its strategic plan and has converted all existing debt into restricted common stock.
Milton Hauser, Chairman and CEO of MedeFile, stated, "The debt conversion has served to materially strengthen our balance sheet, while providing us with additional working capital to help fund our strategic organic growth. This debt conversion will enable management to continue to initiate new sales and marketing programs aimed at increasing the number of subscribers to the MedeFile system. In addition to our ongoing efforts in the wholesale enterprise market, we are now geared up to market to consumers directly through strategic partnerships, various mediums, and physician groups and practices. MedeFile has ramped up our operations in anticipation of our marketing efforts by implementing additional scanning operations, outsourced fulfillment operations and support call centers. We look forward to keeping our shareholders up-to-date on our achievements now and in the future."
The securities offered by MedeFile have not been registered under the Securities Act of 1922 or any state securities laws. Therefore, such securities may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act of 1933 and any applicable state securities laws. This press release does not constitute an offer to purchase any securities or a solicitation of an offer to sell any securities.
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit http://www.medefile.com/
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
CONTACT: MedeFile International, Inc. 877-419-FILE Investor@medefile.com
MedeFile International, Inc.
CONTACT: MedeFile International, Inc. +1-877-419-FILE,
Investor@medefile.com
Web Site: http://www.medefile.com/
© 2010 PR Newswire
BUYINS.NET Updates MedeFile International SqueezeTrigger Report
* Approximately 1.75 Billion Shares Have Been Shorted Since August 2009
* Short Squeeze Expected as Shares Cross Above $.0043 SqueezeTrigger
NEWPORT BEACH, Calif., May 28, 2010 (GLOBE NEWSWIRE) -- BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on MedeFile International (OTCBB:MDFI) after releasing the latest short sale data through May 27, 2010. The total aggregate number of shares shorted since August 2009 is approximately 1.75 billion shares. The SqueezeTrigger price for all shares shorted is $0.0043.
Click for original Report: http://www.buyins.com/reports/mdfi3-17-10.pdf
Click for updated SqueezeTrigger: http://www.buyins.com/images/mdfistr5-28-10.jpg
Click for updated Friction Factor: http://www.buyins.com/images/mdfiff5-28-10.jpg
Friction Factor is used to calculate if a fair market is being made in the shares of (OTCBB:MDFI). 39% of the previous 38 trading days are positive or bullishly-biased and 61% of the trading days are negative or bearishly-biased.
Regulation SHO requires bona-fide market making activities to include making purchases and sales in roughly comparable amounts. The Commission has stated that bona-fide market making DOES NOT include activity that is related to speculative selling strategies or investment purposes of the broker-dealer and is disproportionate to the usual market making patterns or practices of the broker-dealer in that security. Likewise, where a market maker posts continually at or near the best offer, but does not also post at or near the best bid, the market maker's activities would not generally qualify as bona-fide market making. Moreover, a market maker that continually executes short sales away from its posted quotes would generally not be considered to be engaging in bona-fide market making.
BUYINS.NET monitors MDFI market makers daily for compliance with Fair Market-Making Requirements.
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all U.S. stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all U.S. stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 27 billion cell database tracks EVERY short sale (not just total short interest) in all U.S. stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all U.S. stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all U.S. stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. A third party has paid $995 per month to purchase data to be provided in six monthly reports. MDFI has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
CONTACT: BUYINS.NET
Thomas Ronk
800-715-9999
tom@buyins.net
www.buyins.net
Symbol Price Change §
MDFI.OB 0.01 0.00§
Chart for MEDEFILE INTL INC
{"s" : "mdfi.ob","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""}
Press Release Source: MedeFile International, Inc. On Tuesday June 1, 2010, 10:47 am EDT
BOCA RATON, Fla., June 1 /PRNewswire-FirstCall/ -- In a singular development in the field of portable electronic medical records management, MedeFile International, Inc. (OTC Bulletin Board:MDFI.OB.ob - News), already an industry leader in Personal Health Records, has announced the signing of an unprecedented agreement with Dr. Jeffrey Stein, M.D., in which the Doctor and Registered Nurse in the practice will be incorporating MedeFile's PHR technology into its new EMR records system, interfacing directly with MedeFile's platform, thus providing subscribing patients with immediate access to their secure, comprehensive and vital health and medical information.
In anticipation of the launch of this revolutionary program, Dr. Stein's office has been offering the MedeFile PHR package, on a pre-order basis, to the practice's patients. When offered the unparalleled opportunity to consolidate, coordinate and safely store and access their lifelong health history through their primary care physician, an overwhelmingly positive response is being garnered. This first-of-its-kind program allows MedeFile the ability to interface directly with Dr. Stein's EMR solution in order to provide his patients with the most up-to-date information on their healthcare, essentially in real time.
"This program is just tremendous for my practice and my patients, many of whom are snow birds," said Dr. Stein. "They travel frequently, sometimes far from home, and MedeFile's innovations will empower them by giving them total control of and worldwide access to their medical information. Not only can they now access my office records, anytime, anywhere, but participating members can also access any of their other provider's information in their MedeFile as well." Dr. Stein added, "I've been waiting for this technology to become available in this capacity for quite some time, as I believe it is the future of healthcare. MedeFile had demonstrated such integrity and excellence that I am confident my patients will feel the same way as I do about the MedeFile system – that it is invaluable in maintaining one's health and in affecting positive medical outcomes."
Milton Hauser, CEO of MedeFile, was inspired. "This venture is merely the beginning. The incredible response from Dr. Stein's patients speaks to the fact that having the stamp of approval from their doctor is really a tipping point in people making the decision to choose EMR. We will continue to develop and pursue synergistic relationships with private practices, with the goal of providing as many people as possible with anytime anywhere access to their medical records."
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
Contact: Investors, 1-888-241-0800, investor@medefile.com
$
MDFI§
§
Short Interest (Shares Short)
25,000§
Days To Cover (Short Interest Ratio)
0.0§
Short Percent of Float
%§
Short Interest - Prior
25,000§
Short % Increase / Decrease
§248.40 %
Short Squeeze Ranking™
§
% From 52-Wk High ($ 0.02 )
%§
% From 52-Wk Low ($ 0.00 )
%§
% From 200-Day MA ($ 0.00 )
%§
% From 50-Day MA ($ 0.01 )
%§
Price % Change (52-Week)
§455.60 %
Shares Float
0§
Total Shares Outstanding
1,463,021,410§
% Owned by Insiders
§0.00 %
% Owned by Institutions
§0.00 %
Market Cap.
§
$ 7,315,107
Trading Volume - Today
1,348,823§
Trading Volume - Average
3,944,000§
Trading Volume - Today vs. Average
§0.81 %
Earnings Per Share
§
PE Ratio
§
Record Date
2010-JuneA
Sector§
Technology
Industry§
§Healthcare Information Services
Exchange
BB§
Data Provided Without Warranty
Hallo, habe mich soeben erst angemeldet um Ihnen zu Danken für die Arbeit welche Sie hier und anderem leisten. Ich bin hier seit mehreren Monaten mit einem sehr großen Paket drinnen und hoffe, dass sich hier etwas bewegt, zumindest mal auf 0,01 €. So wie es aussieht sollte es diesesmal klappen. Ich denke, dass das neue Krankenkassengesetz durch OBAMA hier hilfreich sein wird oder kann.
Das ist meine persönliche Meinung, sollte kein Kaufsignal sein!!!!!!
-
denke wir sehen hier nächste woche die 0,013$,wie es dann weiter geht bleibt abzuwarten ,bin von der sache total überzeugt und werde long bleiben,alles meine meinung
Viel glück
Earnings Est Current Qtr.
0-00-31§Next Qtr.
0-03-31§Current Year
Dec 09 Next Year
Dec 10
Avg. Estimate N/A N/A N/A N/A
No. of Analysts
Low Estimate N/A N/A N/A N/A
High Estimate N/A N/A N/A N/A
Year Ago EPS N/A N/A N/A N/A
Revenue Est Current Qtr.
0-00-31§Next Qtr.
0-03-31§Current Year
Dec 09 Next Year
Dec 10
Avg. Estimate 6.24M 6.24M 6.24M 19.42M
No. of Analysts 1 1 1 1
Low Estimate 6.24M 6.24M 6.24M 19.42M
High Estimate 6.24M 6.24M 6.24M 19.42M
Year Ago Sales NaN NaN NaN 6.24M
Sales Growth (year/est) N/A N/A N/A 211.20%
Earnings History
EPS Est NaN NaN NaN NaN
EPS Actual NaN NaN NaN NaN
Difference NaN NaN NaN NaN§
Surprise % NaN% NaN% NaN% NaN%
EPS Trends Current Qtr.
0-00-31§Next Qtr.
0-03-31§Current Year
Dec 09 Next Year
Dec 10
Current Estimate NaN NaN NaN NaN
7 Days Ago NaN NaN 0.02 0.05
30 Days Ago NaN NaN 0.02 0.05
60 Days Ago NaN NaN 0.02 0.05
90 Days Ago NaN NaN 0.02 0.05
EPS Revisions Current Qtr.
0-00-31§Next Qtr.
0-03-31§Current Year
Dec 09 Next Year
Dec 10
Up Last 7 Days 0 0
Up Last 30 Days 0 0
Down Last 30 Days 0 0
Down Last 90 Days
Growth Est MDFI.OB Industry Sector S&P 500
Current Qtr. N/A N/A N/A 20.20%
Next Qtr. N/A N/A N/A 18.80%
This Year N/A N/A N/A 35.70%
Next Year N/A N/A N/A 17.60%
Past 5 Years (per annum) 0.00% N/A N/A N/A
Next 5 Years (per annum) N/A N/A N/A N/A
Price/Earnings (avg. for comparison categories) N/A N/A N/A 13.26
PEG Ratio (avg. for comparison categories) N/A N/A N/A N/A
Möglichkeiten.
Entweder es ist hier keiner Investiert!?
Oder sie schlafen alle!!
Die Rakete ist gezündet und hebt langsam ab ....................
Viel Glück uns allen
-
nicht wieder Gewinnmitnahmen bei 0,01 $ machen, dann sollte der Weg weiter gehen als 0,013 $. Mein Gefühl ist um einiges weiter, die Firma ist solide.
Das ist meine persönliche Meinung und keine Kaufanregung!!!
-
mich würde Ihr Rückkaufkurs interesieren. Normaler weise sollte dieser bei 0,007 € liegen. Bei mir ist dieser unverändert und liegt bei 0,005 €. Alle andern US Aktien sind korrekt. Was ist da los?? So einen Scherz kenn ich bis heute nicht. Danke für die Rückantwort.
Das ist meine persönliche Meinung.
-